HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Zosano Pharma Corporation (ZSAN)
1.39  -0.15  (-9.74%) 08-13 01:04
Open: 1.49 High: 1.51
Pre.close: 1.54 Low: 1.28
Volume: 9,616,713 Ave vol: 3,028,020
52w High: 3.21 52w Low: 0.405
MA(50): 0.963 MA(200): 0.831
EPS: -1.107 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.zosanopharma.com
Market Cap (M): 95
Shares Out (M): 69
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its Adhesive Dermally-Applied Microarray technology. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
Technical analysis
Overall: Sell
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bearish
Target 1: 1.92 Target 2: 2.24
Resist 1: 1.64 Resist 2: 1.92
Support 1: 1.09 Support 2: 0.75
Company key metrics
Revenue per Share: 0
Net Income per Share: -1.0365
Cash per Share: 0.1737
Book Value per Share: 0.259
Price to Sales: 0
Price to Book Value: 4.595
Earnings Yield: -0.871
Dividend Yield: 0
Debt to Equity: 3.0109
Debt to Assets: 0.7507
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Wed, 12 Aug 2020
Zosano Pharma Corporation [ZSAN] Plummets -11.69% - News BUR

Wed, 12 Aug 2020
Is Zosano Pharma Corp (ZSAN) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Tue, 11 Aug 2020
Zosano Pharma Corporation 8-K Aug. 11, 2020 4:12 PM - Seeking Alpha

Mon, 10 Aug 2020
Buy or Sell Zosano Pharma Corporation (ZSAN) Stock Now? Don't Try to Be a Top Gun - The News Heater

Thu, 06 Aug 2020
Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™ - GlobeNewswire

Thu, 06 Aug 2020
Zosano Pharma Reports Second Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.